In this new blog series, we review ISO 14971 (Application of risk management to medical devices) - its history, the principles embedded within it and how it relates to other standards and regulation. For the first editio...
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Translation services and the race for a coronavirus vaccine
An article featuring commentary from Adelina Lear regarding the role of language services in the drug development lifecycle.
-
ICON launches Coronavirus Observatory
This article discusses ICON’s Coronavirus Observatory, a tool providing real-time updates on COVID-19 vaccine trials, and insights into key issues.
Read more about ICON's expertise in COVID-19 clinical trials.
-
Role of data in revolutionising the CRO industry
In a wide-ranging interview with PharmaBoardroom, ICON CIO, Tom O’Leary highlights the role of data in revolutionising the CRO industry and the steps that still need to be taken to better match patients with targeted therapies and improve health outcomes.
-
Fast vs. Formulated
An article published by PharmTech.com which features expert commentary from ICON's VP of Drug Development and Consulting, Stuart Madden.
-
Seeking early answers to formulation questions
ICON's Stuart Madden provides expert commentary on drug development in this March 2020 BioPharm International article.
-
Data management landscape is still changing, are we adapting fast enough?
A thought leadership article authored by Rona O’Donnell centred around the changing nature of clinical data management.
-
The Significant Role of a Robust Regulatory Intelligence Process in Global Safety Submissions
Pharmacovigilance insights on the efforts towards the international standardisation of electronic transmission of drug safety information to achieve a unified objective of patient safety, written by Arinder Sihota and Trupti Gurjar, which featured in the March 2020 edition of Pharma Focus.
-
The Power of Patients
ICON's Gretchen Goller contributes to this patient engagement article in PharmaVOICE and outlines how the industry needs to continually evolve and to increase patient centricity from discovery to commercialisation.
-
The Promise of IoMT
A thought leadership article authored by David Novotny and Marie McCarthy, which focuses on the advances in connected devices such as wearable biosensors and mobile trackers.
-
How digital is reversing fortunes in R&D
A new report lays out the ways digital transformation could reverse the trend of declining ROI in pharma R&D.
Tom O’Leary, ICON, Chief Information Officer at ICON outlines a number of factors behind the decline in return on investment (ROI) in this Pharmaphorum article.
